Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care.

National Collaborating Centre for Chronic Conditions (UK).

London: Royal College of Physicians (UK); 2006.

2.

The medical treatment of Parkinson disease from James Parkinson to George Cotzias.

Fahn S.

Mov Disord. 2015 Jan;30(1):4-18. doi: 10.1002/mds.26102. Epub 2014 Dec 9. Review.

PMID:
25491387
3.

[Rating scale and functional prognosis of Parkinson's disease].

Nakano I, Fujimoto K.

Nihon Rinsho. 2000 Oct;58(10):2132-8. Review. Japanese.

PMID:
11068460
4.

Unmet medical needs in Parkinson's disease.

Koller WC, Tse W.

Neurology. 2004 Jan 13;62(1 Suppl 1):S1-8. Review.

PMID:
14718675
5.

Helicobacter pylori eradication for Parkinson's disease.

Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE, Ben-Shlomo Y.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD008453. doi: 10.1002/14651858.CD008453.pub2. Review.

PMID:
22071847
6.

Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.

Lees AJ, Tolosa E, Olanow CW.

Mov Disord. 2015 Jan;30(1):19-36. doi: 10.1002/mds.26120. Epub 2014 Dec 8. Review.

PMID:
25488030
7.

The evolution and origin of motor complications in Parkinson's disease.

Obeso JA, Rodriguez-Oroz MC, Chana P, Lera G, Rodriguez M, Olanow CW.

Neurology. 2000;55(11 Suppl 4):S13-20; discussion S21-3. Review.

PMID:
11147505
8.

Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.

Stowe R, Ives N, Clarke CE, Deane K; van Hilten, Wheatley K, Gray R, Handley K, Furmston A.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007166. doi: 10.1002/14651858.CD007166.pub2. Review.

PMID:
20614454
9.

Amantadine for dyskinesia in Parkinson's disease.

Crosby NJ, Deane KH, Clarke CE.

Cochrane Database Syst Rev. 2003;(2):CD003467. Review.

PMID:
12804468
10.

Cabergoline for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2001;(1):CD001518. Review.

PMID:
11279720
11.

Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.

Deane KH, Spieker S, Clarke CE.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004554. Review.

PMID:
15495119
12.

Treatment of Parkinson's disease: levodopa as the first choice.

Katzenschlager R, Lees AJ.

J Neurol. 2002 Sep;249 Suppl 2:II19-24. Review.

PMID:
12375059
13.

A review of current and novel levodopa formulations for the treatment of Parkinson's disease.

Jimenez-Shahed J.

Ther Deliv. 2016;7(3):179-91. doi: 10.4155/tde.15.96. Review.

PMID:
26893250
14.

Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.

Virhammar J, Nyholm D.

Ther Adv Neurol Disord. 2017 Mar;10(3):171-187. doi: 10.1177/1756285616681280. Epub 2016 Dec 1. Review.

15.
16.

Pergolide for levodopa-induced complications in Parkinson's disease.

Clarke C E, Speller J M.

Cochrane Database Syst Rev. 2000;(2):CD000235. Review.

PMID:
10796704
17.

Amantadine in Parkinson's disease.

Crosby N, Deane KH, Clarke CE.

Cochrane Database Syst Rev. 2003;(1):CD003468. Review.

PMID:
12535476
18.

Levodopa in the treatment of Parkinson's disease: an old drug still going strong.

Poewe W, Antonini A, Zijlmans JC, Burkhard PR, Vingerhoets F.

Clin Interv Aging. 2010 Sep 7;5:229-38. Review.

19.

Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.

Deane KH, Spieker S, Clarke CE.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004553. Review.

PMID:
15495118
20.

Levodopa-related wearing-off in Parkinson's disease: identification and management.

Pahwa R, Lyons KE.

Curr Med Res Opin. 2009 Apr;25(4):841-9. doi: 10.1185/03007990902779319 . Review.

PMID:
19228103

Supplemental Content

Support Center